These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 29629020)

  • 21. What Does a Cardio-oncology Service Offer to the Oncologist and the Haematologist?
    Andres MS; Pan J; Lyon AR
    Clin Oncol (R Coll Radiol); 2021 Aug; 33(8):483-493. PubMed ID: 33832839
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the Cardio-Oncology Study Group of the Heart Failure Association and the Cardio-Oncology Council of the European Society of Cardiology.
    Pudil R; Mueller C; Čelutkienė J; Henriksen PA; Lenihan D; Dent S; Barac A; Stanway S; Moslehi J; Suter TM; Ky B; Štěrba M; Cardinale D; Cohen-Solal A; Tocchetti CG; Farmakis D; Bergler-Klein J; Anker MS; Von Haehling S; Belenkov Y; Iakobishvili Z; Maack C; Ciardiello F; Ruschitzka F; Coats AJS; Seferovic P; Lainscak M; Piepoli MF; Chioncel O; Bax J; Hulot JS; Skouri H; Hägler-Laube ES; Asteggiano R; Fernandez TL; de Boer RA; Lyon AR
    Eur J Heart Fail; 2020 Nov; 22(11):1966-1983. PubMed ID: 33006257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel approaches to the prediction, diagnosis and treatment of cardiac late effects in survivors of childhood cancer: a multi-centre observational study.
    Skitch A; Mital S; Mertens L; Liu P; Kantor P; Grosse-Wortmann L; Manlhiot C; Greenberg M; Nathan PC
    BMC Cancer; 2017 Aug; 17(1):519. PubMed ID: 28774277
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Strategies to Prevent Cardiotoxicity.
    Graffagnino J; Kondapalli L; Arora G; Hawi R; Lenneman CG
    Curr Treat Options Oncol; 2020 Apr; 21(4):32. PubMed ID: 32270293
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The EACVI survey on cardiac imaging in cardio-oncology.
    Stankovic I; Dweck MR; Marsan NA; Bergler-Klein J; Holte E; Manka R; Schulz-Menger J; Sitges M; Haugaa KH
    Eur Heart J Cardiovasc Imaging; 2021 Mar; 22(4):367-371. PubMed ID: 32464650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemotherapy-induced cardiotoxicity in children.
    Bansal N; Amdani S; Lipshultz ER; Lipshultz SE
    Expert Opin Drug Metab Toxicol; 2017 Aug; 13(8):817-832. PubMed ID: 28679288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Role of Advanced Cardiovascular Imaging Modalities in Cardio-Oncology: From Early Detection to Unravelling Mechanisms of Cardiotoxicity.
    Leo I; Vidula M; Bisaccia G; Procopio MC; Licordari R; Perotto M; La Vecchia G; Miaris N; Bravo PE; Bucciarelli-Ducci C
    J Clin Med; 2023 Jul; 12(15):. PubMed ID: 37568347
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Canadian Cardiovascular Society Guidelines for Evaluation and Management of Cardiovascular Complications of Cancer Therapy.
    Virani SA; Dent S; Brezden-Masley C; Clarke B; Davis MK; Jassal DS; Johnson C; Lemieux J; Paterson I; Sebag IA; Simmons C; Sulpher J; Thain K; Thavendiranathan P; Wentzell JR; Wurtele N; Côté MA; Fine NM; Haddad H; Hayley BD; Hopkins S; Joy AA; Rayson D; Stadnick E; Straatman L
    Can J Cardiol; 2016 Jul; 32(7):831-41. PubMed ID: 27343741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exploring the Cardiotoxicity Spectrum of Anti-Cancer Treatments: Definition, Classification, and Diagnostic Pathways.
    Mauro C; Capone V; Cocchia R; Cademartiri F; Riccardi F; Arcopinto M; Alshahid M; Anwar K; Carafa M; Carbone A; Castaldo R; Chianese S; Crisci G; D'Assante R; De Luca M; Franzese M; Galzerano D; Maffei V; Marra AM; Mazza A; Ranieri B; D'Agostino A; Rega S; Romano L; Scagliarini S; Sepe C; Vriz O; Izzo R; Cittadini A; Bossone E; Salzano A
    J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36836147
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardio-Oncology Educational Program: National Survey as the First Step to Start.
    Kozhukhov S; Dovganych N
    Front Cardiovasc Med; 2021; 8():697240. PubMed ID: 34409077
    [No Abstract]   [Full Text] [Related]  

  • 31. Cardio-oncology: what you need to know now for clinical practice and echocardiography.
    Larsen CM; Mulvagh SL
    Echo Res Pract; 2017 Mar; 4(1):R33-R41. PubMed ID: 28254996
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A recommended practical approach to the management of anthracycline-based chemotherapy cardiotoxicity: an opinion paper of the working group on drug cardiotoxicity and cardioprotection, Italian Society of Cardiology.
    Spallarossa P; Maurea N; Cadeddu C; Madonna R; Mele D; Monte I; Novo G; Pagliaro P; Pepe A; Tocchetti CG; Zito C; Mercuro G
    J Cardiovasc Med (Hagerstown); 2016 May; 17 Suppl 1 Special issue on Cardiotoxicity from Antiblastic Drugs and Cardioprotection():e84-e92. PubMed ID: 27755246
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardio-Oncology in Childhood: State of the Art.
    Bennati E; Girolami F; Spaziani G; Calabri GB; Favre C; Parrini I; Lucà F; Tamburini A; Favilli S
    Curr Oncol Rep; 2022 Dec; 24(12):1765-1777. PubMed ID: 36181610
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of a Cardio-Oncology Service in Lithuania: Prediction, Prevention, Monitoring and Treatment of Cancer Treatment-Induced Cardiotoxicity.
    Čiburienė E; Aidietienė S; Ščerbickaitė G; Brasiūnienė B; Drobnienė M; Baltruškevičienė E; Žvirblis T; Čelutkienė J
    J Cardiovasc Dev Dis; 2022 Apr; 9(5):. PubMed ID: 35621845
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cancer Therapy-Related Cardiovascular Complications in Clinical Practice: Current Perspectives.
    Bohdan M; Kowalczys A; Mickiewicz A; Gruchała M; Lewicka E
    J Clin Med; 2021 Apr; 10(8):. PubMed ID: 33924543
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [How to organise cardiovascular management of cancer patients?].
    Thuny F; Cautela J
    Rev Prat; 2018 Mar; 68(3):332-335. PubMed ID: 30869302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardio-oncology: management of cardiovascular toxicity.
    Markman TM; Markman M
    F1000Res; 2019; 8():. PubMed ID: 30755794
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardio-oncology: a multidisciplinary approach for detection, prevention and management of cardiac dysfunction in cancer patients.
    Tajiri K; Aonuma K; Sekine I
    Jpn J Clin Oncol; 2017 Aug; 47(8):678-682. PubMed ID: 28505345
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiovascular safety of oncologic agents: a double-edged sword even in the era of targeted therapies - Part 2.
    Manolis AA; Manolis TA; Mikhailidis DP; Manolis AS
    Expert Opin Drug Saf; 2018 Sep; 17(9):893-915. PubMed ID: 30126303
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monitoring the heart during cancer therapy.
    Habibian M; Lyon AR
    Eur Heart J Suppl; 2019 Dec; 21(Suppl M):M44-M49. PubMed ID: 31908616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.